BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3499730)

  • 1. [Dynamics of the humoral immunity indices in patients with subacute brucellosis being treated with levamisole].
    Mukovozova LA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jul; (7):56-9. PubMed ID: 3499730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of levamisole on the cellular and humoral immunity indices in patients with chronic brucellosis].
    Mukovozova LA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Oct; (10):45-9. PubMed ID: 3265248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of levamisole on the cellular immunity indices of patients with active forms of brucellosis].
    Mukovozova LA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jun; (6):61-5. PubMed ID: 3262973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamics of lymphocyte subpopulations, immunoglobulins and specific antibodies in acute brucellosis].
    Mukovozova LA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):85-9. PubMed ID: 3799106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Free and bound Brucella antigen and the level of circulating immune complexes in brucellosis patients].
    Dranovskaia EA; Arbulieva EA; Gorina LG; Dvurechenskaia GS; Nikiforov ND
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):65-8. PubMed ID: 3716690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reevaluation of the effect of levamisole in chronic brucellosis: in vitro and in vivo effect on monocyte phagocytosis.
    Boura P; Raptopoulou-Gigi M; Acriviadis E; Goulis G
    J Immunopharmacol; 1984; 6(3):135-46. PubMed ID: 6333466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levamisole in the treatment of chronic brucellosis.
    Raptopoulou-Gigi M; Kountouras J; Goulis G
    J Immunopharmacol; 1980; 2(1):85-97. PubMed ID: 7005350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune abnormalities in human brucellosis.
    Gotuzzo E; Bocanegra TS; Alarcón GS; Carrillo C; Espinoza LR
    Allergol Immunopathol (Madr); 1985; 13(5):417-24. PubMed ID: 4083235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cellular and humoral indicators of the immunomodulating effect of levamisole in patients with lymphocytic leukemia].
    Tretiak NN; Koval' AI; Minchenko ZhN; Sverstiuk AE
    Vrach Delo; 1985 Dec; (12):58-61. PubMed ID: 3879409
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of levamisole in murine brucellosis.
    Young EJ; McMillan K
    J Infect Dis; 1987 Sep; 156(3):530-1. PubMed ID: 3611839
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy of various methods of therapy of chronic brucellosis].
    Mukovozova LA
    Ter Arkh; 1987; 59(11):93-6. PubMed ID: 3502037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of levamisole combined with the classical treatment in chronic brucellosis.
    Irmak H; Buzgan T; Karahocagil MK; Evirgen O; Akdeniz H; Demiröz AP
    Tohoku J Exp Med; 2003 Dec; 201(4):221-8. PubMed ID: 14690014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [State of cellular and humoral immunity in recurrent and chronic bronchopulmonary diseases in children before and after immunostimulation with levamisole].
    Błaszczyk E; Kulczyk BA
    Wiad Lek; 1985 Apr; 38(7):495-9. PubMed ID: 3874484
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of levamisole as an immunomodulating agent in trophoblastic lesions.
    Khanna A; Ojha KN; Gupta RM
    Indian J Pathol Microbiol; 1993 Jan; 36(1):32-7. PubMed ID: 8354552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy in chronic brucellosis. Effect of levamisole and interferon; mechanisms of action and clinical value.
    Printzis S; Raptopoulou-Gigi M; Orphanou-Koumerkeridou H; Lagre F; Goulis G
    Immunopharmacol Immunotoxicol; 1994 Nov; 16(4):679-93. PubMed ID: 7876467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brucellosis, immunodepression, and levamisole.
    Renoux M; Renoux G
    Lancet; 1977 Feb; 1(8007):372. PubMed ID: 64900
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-immunological aspects of using levamisole in psychiatric practice].
    Semenov SF; Golodets RG; Avrutskiĭ GIa; Maksutova EL; Mogilina NP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(1):100-7. PubMed ID: 3364086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic disorders in endogenous uveitis and the possible means of their correction by drugs].
    Vanichkin AA; Shpak NI
    Oftalmol Zh; 1982; 37(1):10-3. PubMed ID: 6979018
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunomodulating action of levamisole in its combined use with influenza vaccines].
    Obrosova-Serova NP; Schastnyĭ EI; Kupriashina LM; Slepushkin AN; Shenderovich SF
    Vopr Virusol; 1984; 29(4):454-9. PubMed ID: 6208690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative effectiveness of levamisole and vaccine in the complex treatment of patients with brucellosis].
    Mukovozova LA
    Ter Arkh; 1986; 58(10):43-5. PubMed ID: 3541274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.